Risk of Aerosol Formation During High-Flow Nasal Cannula Treatment in Critically Ill Subjects

References

1. 1.↵
   1. Somsen GA,
   2. van Rijn C,
   3. Kooij S,
   4. Bem RA,
   5. Bonn D

   . Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission. Lancet Respir Med 2020;8(7):658-659.

   OpenUrl
2. 2.↵
   1. Bourouiba L

   . Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19. JAMA 2020;323(18):1837-1838.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Fennelly KP

   . Particle sizes of infectious aerosols: implications for infection control. Lancet Respir Med 2020;8(9):914-924.

   OpenUrl
4. 4.↵
   1. Smith SH,
   2. Somsen GA,
   3. van Rijn C,
   4. Kooij S,
   5. van der Hoek CM,
   6. Bem RA,
   7. Bonn D

   . Aerosol persistence in relation to possible transmission of SARS-CoV-2. Phys Fluids (1994) 2020;32(10):107108.

   OpenUrl
5. 5.↵
   1. Ari A

   . Use of aerosolised medications at home for COVID-19. Lancet Respir Med 2020;8(8):754-756.

   OpenUrl
6. 6.↵
   1. Phua J,
   2. Weng L,
   3. Ling L,
   4. Egi M,
   5. Lim CM,
   6. Divatia JV,
   7. et al

   . Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med 2020;8(5):506-517.

   OpenUrl
7. 7.↵
   1. Klompas M,
   2. Baker M,
   3. Rhee C

   . What is an aerosol-generating procedure? JAMA Surg 2021;156(2):113.

   OpenUrl
8. 8.↵
   1. Cheung JC,
   2. Ho LT,
   3. Cheng JV,
   4. Cham EYK,
   5. Lam KN

   . Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med 2020;8(4):e19.

   OpenUrl
9. 9.↵
   1. Alhazzani W,
   2. Møller MH,
   3. Arabi YM,
   4. Loeb M,
   5. Gong MN,
   6. Fan E,
   7. et al

   . Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 2020;46(5):854-887.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Gaeckle NT,
    2. Lee J,
    3. Park Y,
    4. Kreykes G,
    5. Evans MD,
    6. Hogan CJ Jr..

    Aerosol Generation from the Respiratory Tract with Various Modes of Oxygen Delivery. Am J Respir Crit Care Med 2020;202(8):1115-1124.

    OpenUrlCrossRefPubMed
11. 11.
    1. Li J,
    2. Ehrmann S

    . High-flow aerosol-dispersing versus aerosol-generating procedures. Am J Respir Crit Care Med 2020;202(8):1069-1071.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Li J,
    2. Fink JB,
    3. Ehrmann S

    . High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J 2020;55(5):2000892.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Li J,
    2. Fink JB,
    3. Elshafei AA,
    4. Stewart LM,
    5. Barbian HJ,
    6. Mirza SH,
    7. et al

    . Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion. ERJ Open Res 2021;7(1):00519-2020.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Vianello A,
    2. Arcaro G,
    3. Molena B,
    4. Turato C,
    5. Sukthi A,
    6. Guarnieri G,
    7. et al

    . High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection. Thorax 2020;75(11):998-1000.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Raboud J,
    2. Shigayeva A,
    3. McGeer A,
    4. Bontovics E,
    5. Chapman M,
    6. Gravel D,
    7. et al

    . Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One 2010;5(5):e10717.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Leung CCH,
    2. Joynt GM,
    3. Gomersall CD,
    4. Wong WT,
    5. Lee A,
    6. Ling L,
    7. et al

    . Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. J Hosp Infect 2019;101(1):84-87.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Haymet A,
    2. Bassi GL,
    3. Fraser JF

    . Airborne spread of SARS-CoV-2 while using high-flow nasal cannula oxygen therapy: myth or reality? Intensive Care Med 2020;46(12):2248-2251.

    OpenUrl
18. 18.↵
    1. Somsen GA,
    2. van Rijn CJM,
    3. Kooij S,
    4. Bem RA,
    5. Bonn D

    . Measurement of small droplet aerosol concentrations in public spaces using handheld particle counters. Phys Fluids (1994) 2020;32(12):121707.

    OpenUrl
19. 19.↵
    1. Ahn JY,
    2. An S,
    3. Sohn Y,
    4. Cho Y,
    5. Hyun JH,
    6. Baek YJ,
    7. et al

    . Environmental contamination in the isolation rooms of COVID-19 patients with severe pneumonia requiring mechanical ventilation or high-flow oxygen therapy. J Hosp Infect 2020;106(3):570-576.

    OpenUrl
20. 20.↵
    1. van Doremalen N,
    2. Bushmaker T,
    3. Morris DH,
    4. Holbrook MG,
    5. Gamble A,
    6. Williamson BN,
    7. et al

    . Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382(16):1564-1567.

    OpenUrlCrossRefPubMed